Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

SELF-TEST FOR GLUCOSE - ANVISA Registration 80867150211

Access comprehensive regulatory information for SELF-TEST FOR GLUCOSE in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80867150211 and manufactured by manufacturer not specified. The registration is held by BIOMOLECULAR TECHNOLOGY COMÉRCIO, IMPORTAÇÃO, EXPORTAÇÃO E DISTRIBUIÇÃO DE MATERIAIS MÉDICOS E LABORATORIAIS LTDA - EPP with validity until Apr 28, 2035.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 companies making the same product including OK BIOTECH CO., LTD., ROCHE DIABETES CARE GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
80867150211
2 Related Devices
Registration Details
ANVISA Registration Number: 80867150211
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Related Devices (2)

FAMILIA DE SOLUÇÃO CONTROLE OK PRO ( OK PRO Control Solution)
Risk Class III

Registration Details

80867150211

25351418531202481

07767477000146

Dates and Status

Apr 28, 2025

28/04/2035

09/18/2025 19:00:01

FAMILIA DE SOLUÇÃO CONTROLE OK PRO ( OK PRO Control Solution)
Risk Class III

Registration Details

80867150211

25351418531202481

07767477000146

Dates and Status

Apr 28, 2025

28/04/2035

09/18/2025 19:00:01